CD44 and breast carcinoma: We have previously observed that TN breast cancer cells (including the MDA-MB-231, SUM149, and SUM159 models used in this study) express high levels of the standard form of CD44 (CD44S) on their cell surface [15], suggesting a potential mechanism by which lung-derived selectins might influence breast cancer cell behavior.